发明名称 Cd45 inhibitors
摘要 Substituted phenanthrene-9,10-diones in accord with structural diagram I, compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In compounds of the invention, R<1 >at each occurrence is independently selected from hydrogen, halogen, NH-tosyl, N-di-tosyl, NH2, NO2, NH-CO-R<2>, CO-NH-R<2>, Ar, (CH2)nCH(COOH)R<3 >COR<3 >and NHCOCH2CH(COOH)NHR<4>, where R<2>, R<3 >and R<4 >are a selected from a variety of substituted or unsubstituted alkyl and aryl groupstand oligopeptides.
申请公布号 US2003207812(A1) 申请公布日期 2003.11.06
申请号 US20020168758 申请日期 2002.11.25
申请人 CHAPDELAINE MARC JEROME;KNAPPENBERGER KATHARINE;STEELMAN GARY;SUCHARD SUZANNE;SYGOWSKI LINDA;URBANEK REBECCA;VEALE CHRIS ALLAN 发明人 CHAPDELAINE MARC JEROME;KNAPPENBERGER KATHARINE;STEELMAN GARY;SUCHARD SUZANNE;SYGOWSKI LINDA;URBANEK REBECCA;VEALE CHRIS ALLAN
分类号 C07D317/54;A61K31/122;A61K31/136;A61K31/166;A61K31/167;A61K31/18;A61K31/192;A61K31/198;A61K31/223;A61K31/225;A61K31/27;A61K31/343;A61K31/36;A61K31/381;A61K38/00;A61P37/02;C07C50/16;C07C50/20;C07C50/24;C07C50/34;C07C50/38;C07C205/46;C07C225/32;C07C233/33;C07C233/76;C07C235/16;C07C235/38;C07C235/74;C07C235/84;C07C237/22;C07C311/21;C07C311/48;C07C311/51;C07D307/80;C07D317/26;C07D333/22;C07K5/06;C07K5/072;C07K5/113;C07K7/06;(IPC1-7):A61K38/08;A61K38/04;C07K5/04;C07D317/46;C07D333/02 主分类号 C07D317/54
代理机构 代理人
主权项
地址